Elevation Oncology (ELEV)
(Delayed Data from NSDQ)
$0.78 USD
+0.02 (2.34%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $0.77 -0.01 (-1.03%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Elevation Oncology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -45.70 | -95.08 | -32.04 | -17.27 | NA |
Depreciation/Amortization & Depletion | -0.82 | -0.18 | 0.02 | 0.02 | NA |
Net Change from Assets/Liabilities | -13.69 | 6.29 | 0.28 | 4.90 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 4.04 | 3.49 | 1.57 | 0.05 | NA |
Net Cash From Operating Activities | -56.18 | -85.48 | -30.17 | -12.30 | NA |
Property & Equipment | 0.00 | -0.09 | 0.00 | -0.07 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 11.54 | -44.31 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 11.54 | -44.40 | 0.00 | -0.07 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 47.98 | -0.02 | 97.06 | 90.20 | NA |
Issuance (Repayment) of Debt | 0.00 | 30.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | -0.47 | -0.01 | -0.17 | NA |
Net Cash from Financing Activities | 47.98 | 29.51 | 97.05 | 90.03 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | 3.34 | -100.37 | 66.88 | 77.66 | NA |
Cash at Beginning of Period | 45.92 | 146.28 | 79.40 | 1.74 | NA |
Cash at End of Period | 49.26 | 45.92 | 146.28 | 79.40 | NA |
Diluted Net EPS | -1.34 | -4.09 | -2.64 | NA | NA |
Fiscal Year End for Elevation Oncology, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -21.17 | -10.71 | -45.70 | -37.81 | -27.17 |
Depreciation/Amortization & Depletion | -0.61 | -0.27 | -0.82 | -0.35 | -0.16 |
Net Change from Assets/Liabilities | 0.84 | -0.61 | -13.69 | -9.41 | -5.86 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.16 | 2.01 | 4.04 | 3.57 | 2.55 |
Net Cash From Operating Activities | -17.78 | -9.58 | -56.18 | -44.00 | -30.64 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -16.96 | 20.70 | 11.54 | 4.98 | 43.10 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -16.96 | 20.70 | 11.54 | 4.98 | 43.10 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 45.10 | 30.40 | 47.98 | 47.98 | 47.95 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.17 | -0.15 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 44.93 | 30.25 | 47.98 | 47.98 | 47.95 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 10.19 | 41.38 | 3.34 | 8.96 | 60.41 |
Cash at Beginning of Period | 49.26 | 49.26 | 45.92 | 45.92 | 45.92 |
Cash at End of Period | 59.45 | 90.63 | 49.26 | 54.88 | 106.33 |
Diluted Net EPS | -0.18 | -0.23 | -0.19 | -0.25 | -0.37 |